TEDCO’s Maryland Innovation Initiative Announces FY2025 Technology Assessment Awards

Over $1 million awarded to 7 university projects 

COLUMBIA, Md., April 24, 2025 /PRNewswire/ — TEDCO, Maryland’s economic engine for technology companies, announced the next round of Maryland Innovation Initiative (MII)’s Technology Assessment awards, marking a significant milestone in promoting the commercialization of groundbreaking research from Maryland’s prestigious academic research institutions. The Technology Assessment award is a nine-month project that builds on strong preliminary data that demonstrates the technology’s utility for specific commercial applications beyond basic research. 

Over $1 million awarded to 7  university projects in Maryland

“The Technology Assessment phase of our program provides non-dilutive funding to advance technologies with commercial potential,” said Abi Kulshreshtha, MII’s executive director. “In this award cycle, the Maryland Innovation Initiative staff and technical reviewers selected seven projects from a competitive pool of applicants, which altogether received grants totaling more than $1 million to advance innovations ranging from new cancer therapeutics to inclusive AI-driven education technology solutions.”

The seven awardees are below:

  • Heather Ames: Cell-HKer/siRaf, a promising therapeutic for Solid Tumors; University of Maryland, Baltimore
  • Kevin Aroom: The Baby Gro Pro Smartscale: improving early diagnosis of medical problems and rare diseases; University of Maryland, College Park
  • Steven Bernstein: Development of a novel optic nerve-stem cell therapy for glaucoma prevention and treatment; University of Maryland, Baltimore
  • Won Jin Ho: Targeting PTPN22 for cancer immunotherapy; Johns Hopkins University
  • Melanie Killen: Utilizing natural language processing technology for creating inclusive classrooms resubmission; University of Maryland, College Park
  • Yuxing Li: Development and evaluation of a C. difficile-specific endolysin and dual therapy for C. difficile infection; University of Maryland, Baltimore
  • Venkataramana Sidhaye: Development of a novel inhaled gene therapy, based on HAPLN1 transgene expression, for treating COPD; Johns Hopkins University

Startup companies joining TEDCO’s MII portfolio have access to a variety of TEDCO resources including mentor opportunities. A complete list of funded companies can be found on the MII webpage (here).

MII’s Funding Opportunities

The MII program, administered by TEDCO, was created as a collaboration between the State of Maryland and five leading academic research institutions—Johns Hopkins University, Morgan State University, University of Maryland, Baltimore, University of Maryland, Baltimore County, and University of Maryland, College Park— that aims to leverage each institution’s strengths to transition promising technologies into the commercial sector.

“MII continues to bring innovation from lab to market,” said Renée Winsky, chair of the MII Board of Directors. “Since inception, it has supported the creation of nearly 400 jobs, created or supported more than 190 startups, and invested over $58 million in the Maryland innovation ecosystem and we look forward to continuing this progress.”

MII has also expanded its reach to include two additional comprehensive universities, Frostburg State University and Bowie State University, along with the creation of the Baltimore Innovation Initiative (BII). All of these pilot programs aim to foster a more equitable innovation and entrepreneurial ecosystem across Maryland.

For more information, visit the MII webpage.

About TEDCO
TEDCO, the Maryland Technology Development Corporation, enhances economic empowerment growth through the fostering of an inclusive entrepreneurial innovation ecosystem. TEDCO identifies, invests in, and helps grow technology and life science-based companies in Maryland. Learn more at www.tedcomd.com.

Media Contact
Tammi Thomas, Chief Development & Marketing Officer, TEDCO, tthomas@tedcomd.com
Rachael Kalinyak, Associate Director, Marketing & Communications, TEDCO, rkalinyak@tedcomd.com 

View original content to download multimedia:https://www.prnewswire.com/news-releases/tedcos-maryland-innovation-initiative-announces-fy2025-technology-assessment-awards-302437566.html

SOURCE TEDCO

Staff

Recent Posts

Vent Creativity Appoints Paul Abrams as Vice President of Sales to Lead Commercial Growth

NEW YORK--(BUSINESS WIRE)--Vent Creativity, a medical technology company advancing AI-enabled surgical planning, today announced the…

5 hours ago

AEON Clinic Announces Next Generation Medicine Congress 2026 Event: A Global Convergence on Human Longevity in Dubai

AEON Clinic Elevates Dubai to Global Hub for Longevity Science, A Definitive Four-Day Summit Defining…

5 hours ago

AI-Era Position Statement to Protect the Integrity of Healthcare, Technology, and Services Benchmarking published by Black Book Research

Black Book outlines an AI-era integrity architecture for healthcare benchmarking, instrumentation hardening, tiered verification, real-time…

1 day ago

New employee representative on the Board of Directors of Novo Nordisk A/S

Bagsværd, Denmark, 31 January 2026 – Thomas Rantzau, employee representative on the Board of Directors since…

1 day ago

Embers to Empowerment: The Womb Room Reopens in Govans, Expanding Community-Centered Perinatal Care After Hampden Fire

Baltimore, Maryland, Jan. 31, 2026 (GLOBE NEWSWIRE) -- After sustaining water damage during the massive…

1 day ago

Oxford Healthspan to Introduce New Primeadine® GF Powder Through a ‘Longevity Shot’ Experience During Grammy Week in Los Angeles

Science-Backed Spermidine Ritual Brings Cellular Renewal to a High-Performance Cultural Moment Primeadine Longevity Shot Primeadine…

1 day ago